Paperpal Prime Logo

Multiple Sclerosis Journal - Experimental, Translational and Clinical : Impact Factor & More

eISSN: 2055-2173pISSN: 2055-2173
JournalOpen Access

Key Metrics

CiteScore
3.3
SJR
Q4Neurology (clinical)
SNIP
0.8
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Multiple Sclerosis Journal - Experimental, Translational and Clinical

Multiple Sclerosis Journal - Experimental, Translational and Clinical Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS INC
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2000
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Multiple Sclerosis Journal - Experimental, Translational and Clinical ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Multiple Sclerosis Journal - Experimental, Translational and Clinical

Family planning and multiple sclerosis \u2013 Part 1: Patient perspectives on treatment choices in Sweden
  • 5 Aug 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Anti-CD20 associated enterovirus meningoencephalitis: A narrative review with two illustrative cases
  • 28 Jul 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Family planning and multiple sclerosis \u2013 part 2: Does real-world practice align with Swedish treatment guidelines?
  • 24 Jul 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Insights from a Danish nationwide implementation of patient-reported outcomes in multiple sclerosis
  • 23 Jul 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Circulating microRNA expression profiles as biomarkers of disease activity in multiple sclerosis
  • 23 Jul 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Epidemiology of multiple sclerosis in a healthcare area of the Basque Country, Northern Spain: A population-based study (2009\u20132023)
  • 16 Jun 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Family planning and multiple sclerosis \u2013 Part 1: Patient perspectives on treatment choices in Sweden
  • 5 Aug 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Anti-CD20 associated enterovirus meningoencephalitis: A narrative review with two illustrative cases
  • 28 Jul 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Family planning and multiple sclerosis \u2013 part 2: Does real-world practice align with Swedish treatment guidelines?
  • 24 Jul 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Insights from a Danish nationwide implementation of patient-reported outcomes in multiple sclerosis
  • 23 Jul 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Circulating microRNA expression profiles as biomarkers of disease activity in multiple sclerosis
  • 23 Jul 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Epidemiology of multiple sclerosis in a healthcare area of the Basque Country, Northern Spain: A population-based study (2009\u20132023)
  • 16 Jun 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical

FAQs on Multiple Sclerosis Journal - Experimental, Translational and Clinical